HOXA9 and Leber congenital amaurosis: APC, HOXA9, RARβ2, and RASSF1A promoter methylation levels were evaluated in plasma samples from benign lung disease and LCa patients to assess whether they might differ among malignant and benign lung disease (Figure 1).